SCHEMBL4697346

SCHEMBL4697346

CCN(CC)C(=O)N1CCN(Cc2ccc(-c3ccccc3C(F)(F)F)cc2)CC1c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.56
TACR1 P25103 8/20 0.48
TACR2 P21452 2/20 0.44
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MLNR O43193 1/20 0.41
CYP3A4 P08684 1/20 0.41
P2RX7 Q99572 1/20 0.40
DPP4 P27487 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471731 0.92 CNR2 (0.58) CNR2TACR1TACR2KDM4EMEN1
SCHEMBL4483088 0.88 CNR2 (0.60) CNR2TACR1TACR2KDM4EALDH1A1
SCHEMBL4479887 0.86 CNR2 (0.58) CNR2TACR1TACR2KDM4EMEN1
SCHEMBL4488066 0.85 CNR2 (0.57) CNR2TACR1TACR2KDM4EMEN1
SCHEMBL4480824 0.85 CNR2 (0.59) CNR2TACR1TACR2KDM4EALDH1A1
SCHEMBL4472304 0.84 CNR2 (0.58) CNR2TACR1TACR2KDM4EALDH1A1
SCHEMBL4469512 0.83 CNR2 (0.56) CNR2TACR1TACR2KDM4EMAPT
SCHEMBL4468418 0.81 CNR2 (0.64) CNR2KDM4EALDH1A1MEN1KMT2A
SCHEMBL4489036 0.81 CNR2 (0.64) CNR2TACR1KDM4EALDH1A1MEN1
SCHEMBL4476107 0.80 CNR2 (0.66) CNR2TACR1KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966132-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-09-10 EP disclosed
WO-2007070760-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 WO disclosed